Canada Pension Plan Investment Board’s Beam Therapeutics BEAM Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Sell	6,500 -2,700	-29%	-$81.5K	﹤0.01%	1571
2026 Q1	$219K	Buy	+9,200	New	+$255K	﹤0.01%	1544
2023 Q1	–	Sell	-1,399	Closed	-$54.7K	–	1072
2022 Q4	$54.7K	Sell	1,399 -2,100	-60%	-$94.1K	﹤0.01%	1069
2022 Q3	$167K	Sell	3,499 -1,800	-34%	-$103K	﹤0.01%	1048
2022 Q2	$205K	Buy	5,299 +3,800	+254%	+$151K	﹤0.01%	1077
2022 Q1	$86K	Buy	+1,499	New	+$98.3K	﹤0.01%	1192

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Canada Pension Plan Investment Board's BEAM Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Beam Therapeutics (BEAM) stake by 29% in Q2 2026, selling an estimated $81.5K and leaving 6,500 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Canada Pension Plan Investment Board first reported a position in BEAM in Q1 2022 and has held it in 6 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Canada Pension Plan Investment Board held 6,500 shares of Beam Therapeutics worth $223K as of Q2 2026.
Canada Pension Plan Investment Board sold 2,700 Beam Therapeutics shares in Q2 2026, an estimated $81.5K.
Beam Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1571 holding.
Canada Pension Plan Investment Board first reported a position in Beam Therapeutics in Q1 2022 and has held it in 6 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.